The UK company is the latest to join ranks of AI-focused drugmakers attracting venture capital.
The researcher who invented Viagra and a colleague at Cambridge University have become the latest to join the ranks of drug developers using artificial intelligence and attracting attention from venture capitalists.
Cambridge, UK-based Healx said Thursday that it had raised $10 million in a Series A funding round, led by London-based venture capital firm Balderton Capital. Fellow British venture capital firm Amadeus Capital Partners and Jonathan Milner – founder of life sciences supplier Abcam – also participated. Cambridge Rare Diseases Network founder Tim Guilliams and David Brown – who invented Pfizer’s erectile dysfunction drug, which is now available as a generic – are the founders of Healx.
The company uses the HealNet database, which maps more than 1 billion disease, patient and drug interactions and was built and maintained using machine learning techniques. The company plans to use the Series A round to expand its team of software engineers, data scientists, pharmacologists and drug development researchers.
Image Credit: Alias Studio Sydney
News This Week
A red-hot anti-aging strategy quietly passed its first test earlier this year after 14 volunteers took drugs meant to kill off old, toxic cells in their bodies. The small study in people with [...]
Since the discovery of biological ion channels and their role in physiology, scientists have attempted to create man-made structures that mimic their biological counterparts. New research by Lawrence Livermore National Laboratory (LLNL) scientists and [...]
Sometimes it is too cold for us and then too warm again - annoying dressing-undressing of sweaters and co. Is therefore required. However, that may change: researchers have developed a sophisticated textile that can [...]
What is Global Health Care Equivalency (GHCE)? Looking ahead over the next 10-30 years, with the rapid emergence of, and synergies between, the disciplines of nanotechnology, nanomedicine, and AI, we can envisage a future [...]
Researchers in Singapore have built a refrigerator that’s just three atoms big. This quantum fridge won’t keep your drinks cold, but it’s cool proof of physics operating at the smallest scales. The work is [...]
Note: This videoblog is in German. It was produced by the Institute of Art & Art Theory of the University of Cologne. Humanity faces epochal challenges in the age of digitization. In particular, [...]
NanoApps Medical Inc. CEO Frank Boehm has signed with IOP Publishing to produce Nanomedical Brain/Cloud Interface: Explorations and Implications - a book that will explore the notion of a nanomedically enabled Brain/Cloud Interface (B/CI). [...]
Scientists from the University of Bath (UK) and Northwestern University (USA) have developed a new type of sensor platform using a gold nanoparticle array, which is 100 times more sensitive than current similar [...]
Scientists have developed tiny elastic robots that can change shape depending on their surroundings. Modeled after bacteria and fully biocompatible, these robots optimize their movements so as to get to hard-to-reach areas of the [...]
A pea-sized device used to seal tiny but potentially deadly holes in the hearts of premature infants has been approved by U.S. regulators, making it one of the smallest complex medical devices ever invented [...]
Scientists have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism. The findings could bring about a better [...]
Nanotechnology may well be one of the most talked about industries of the last few years. Predicted to value US$173.95 billion globally by 2025, this fast-moving sector is already delivering major sustainability, health and [...]